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Abstract
Several studies have measured the association between
blood or adipose concentrations of organochlorinated
compounds (OCs), such as pesticides and polychlorinated
biphenyls (PCBs), and breast cancer. The estrogenic
effects of OCs might adversely affect breast cancer
recurrence. The participants were 224 women with
nonmetastatic breast cancer enrolled in a New York-
based case-control study. Supercritical fluid extraction
followed by gas chromatography was conducted on
adipose surgical specimens to determine OC
concentrations. The mean follow-up time from surgery
was 3.6 years. Thirty women (13.4%) were diagnosed
with a recurrence. The concentration of pesticides and
PCBs was correlated with baseline age and body mass
index, but not with cancer stage. The highest tertile of
total PCB concentration was associated with an increased
risk of recurrence [relative risk (RR), 2.9; 95%
confidence interval (CI), 1.02–8.2 versus the lowest
tertile]. The risk for the highest tertile of the PCB
congener Ballschmiter and Zell 118 was 4.0 (95% CI,
1.3–4.9). There was an increased risk for the middle level
of the most abundant pesticide, 1,1-dichloro-2,2-di(4-
chlorophenyl)ethylene (RR, 2.3; 95% CI, 0.9–5.7), and
for -hexachlorocyclohexane, but not for their highest
levels. Self-reported home termiticide exposure, alcohol
consumption (>1 drink/day), and race were not
associated with prognosis. The RR for current cigarette
smoking at diagnosis was 2.1 (95% CI, 0.9–5.1). In
contrast to previous data showing no relationship
between OC exposure and risk of breast cancer in these
women, adipose PCB concentrations were associated with
tumor recurrence. Pesticide levels were not related to
recurrence.
Introduction
The IARC classifies organochlorinated compounds (OCs) as
probable or possible human carcinogens (1). OC compounds
include agricultural pesticides such as 1,1,1-trichloro-2,2-bis(p-
chlorophenyl)ethane and the industrial polychlorinated biphe-
nyls (PCBs). Although domestic use was banned in the 1970s,
OCs persist ubiquitously in the environment, wildlife, and
human adipose tissue.
The estrogenic properties of OCs (2) are thought to in-
crease the risk of breast cancer. Estrogens possibly promote the
development of breast cancer by increasing cellular prolifera-
tion, and some studies found that women with high circulating
blood estrogen levels or with a history of postmenopausal
estrogen use had increased breast cancer rates (3). There have
been several studies of OC concentrations in blood or adipose
tissue and breast cancer risk. In general, positive associations
were observed in earlier studies, whereas more recent investi-
gations found no effects or increased risks only in study sub-
groups (4). Environmental exposures to OCs are also thought to
affect the progression of breast cancer. High blood levels of
1,1-dichloro-2,2-di(4-chlorophenyl)ethylene (p,p-DDE) were
correlated with more extensive lymph node involvement in one
report (5), and elevated blood concentrations of dieldrin but not
other OCs were associated with increased breast cancer mor-
tality in a Danish study (6). In the current investigation, we
examined whether adipose OC concentrations were associated
with the risk of breast cancer recurrence.
Materials and Methods
The women in this study were participants in our hospital-based
case-control study of OC concentrations and breast cancer risk in
Long Island, New York (7). The case-control study included 359
women who were newly diagnosed at Long Island Jewish Medical
Center (New Hyde Park, NY) and North Shore University Hos-
pital (Manhasset, NY) between 1994 and 1996. More than 95% of
eligible patients participated. Trained study personnel interviewed
the women before surgery using a structured questionnaire that
contained items on known and suspected breast cancer risk factors.
Three hundred and eight women (86%) agreed to provide breast
adipose tissue samples, which were obtained at surgery and im-
mediately frozen. Concentrations of pesticides and PCBs were
determined for 232 randomly selected case women by supercritical
fluid extraction and gas chromatography with electron capture
(8). The pesticides included 1,1,1-trichloro-2,2-bis(4-chlorophe-
nyl)ethane, 1,1-dichloro-2-(ortho-chlorophenyl)-2-(para-chloro-
phenyl)ethane, p,p-DDE, trans-nonachlor, oxychlordane, -hexa-
chlorocyclohexane, and hexachlorobenzene. The PCB congeners
included Ballschmiter and Zell (BZ) 74, BZ 99, BZ 118, BZ 138,
BZ 146, BZ 153, BZ 156, BZ 167, BZ 170, BZ 172, BZ 178, BZ
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180, BZ 183, and BZ 187. The limits of detection were reported
previously and ranged from 0.069 (oxychlordane, t-nonachlor) to
0.723 ng/g [BZ 153 and BZ 180 (8)]. Nondetectable concentra-
tions were coded as zero.
The women were followed for up to 5 years after surgery
to determine their health status. Medical records were reviewed
to determine the date of any subsequent recurrence, tumor
stage, histology, hormone receptor status, hormone treatment,
chemotherapy, radiation, and other postoperative care. The
stage of cancer was determined using the American Joint Com-
mittee on Cancer criteria (9). Recurrence was defined as the
development of a postoperative tumor in the same breast, re-
gional spread of the primary tumor, or metastatic spread to vital
organs. A subsequent primary cancer in the contralateral breast
was not defined as a recurrence. The women were mailed a
short survey to determine postdiagnosis changes in smoking
habits, weight, and other factors. If a participant failed to return
the questionnaire, additional requests were made by follow-up
telephone calls and home visits. The data analysis was based on
224 women because 8 of the 232 women presented with ad-
vanced-stage disease at diagnosis. The follow-up questionnaire
was completed by 185 (82.6%) women. Consequently, the
sample size for some analyses was 185. All patients signed a
consent form that was approved by the Institutional Review
Boards of the Institute for Cancer Prevention and the partici-
pating medical centers.
Data analysis was conducted using SAS statistical soft-
ware (Version 8.2; Cary, NC). Descriptive statistics were cal-
culated including frequency tables and means and SDs. Spear-
man correlation coefficients were calculated to determine the
associations between log OC concentrations and age, body
mass index (BMI), and stage of disease at diagnosis. The
association between weight at baseline and weight at the time
of follow-up was determined by the Pearson correlation coef-
ficient. Proportional hazard models were fit to estimate the
relative risks (RRs) and corresponding 95% confidence inter-
vals (CIs) of breast cancer recurrence in relation to log-trans-
formed concentrations of OCs. Subjects were grouped into
tertiles based on the distribution of log-transformed values (ln
1 to account for values of zero). Ps were based on two-sided
tests. Initial models included terms for the effects of known
confounders including age and BMI [weight (kg)/height2 (m)].
The independent and potential confounding effects of other risk
factors at the time of diagnosis were also evaluated including
cancer stage, education, smoking (current versus not current),
and alcohol consumption (1 drink/day versus 1 drink/day).
Estrogen receptor (ER) assays are usually performed for
women with invasive tumors. In the current study, ER assays
were performed on 185 women (83%). Adjuvant hormonal
therapy is routinely administered to women with ER tumors,
except where contraindicated or if refused. However, it is also
administered routinely as treatment for ductal carcinoma in situ
and to younger women. The majority of women who are ER–
are not treated with adjuvant estrogen therapy. Consequently,
statistical adjustment was also made for adjuvant hormone
therapy (treatment versus no treatment).
All terms were modeled as categorical variables except for
BMI, which was treated as a continuous variable. Tests for
trends were conducted by modeling OC concentrations as con-
tinuous variables. Departures from the proportional hazard
model assumption were tested by inclusion of a time-dependent
interaction term.
Results
Table 1 shows the age and tumor characteristics of the 224
women. Seventy-four subjects (33.0%) were 50 years old, 23
(10.3%) were black, and 3 (1.3%) were Asian. The most com-
mon histological type was ductal carcinoma (72.3%). About
65% of subjects had early-stage disease, and 35% had stage II
or III disease. There were 30 (13.4%) recurrences during the
follow-up period.
Table 2 shows the mean and SD of the OC concentrations
by recurrence status, with nondetects treated as zero values. The
pesticide residue and PCB congener with the highest mean
concentration were p,p-DDE and BZ 153, respectively. The
mean total pesticide and PCB concentrations were both about
10% higher in blacks than in whites.
The Spearman correlation coefficients between age at di-
agnosis and total pesticide and PCB concentrations were both
about 0.54 (Table 3). For BMI, the r was 0.35 for total pesticide
concentrations and 0.14 for total PCB concentrations. Cancer
stage was not correlated with OC levels. The Pearson correla-
tion between BMI at the time of diagnosis and that reported on
the follow-up questionnaire was 0.90. For subjects who expe-
rienced a recurrence, the r was 0.92 (n  23).
The mean length of time between the date of surgery and
the date of the follow-up (or date of recurrence) was 3.6 years.
Proportional hazard model results are shown in Tables 4 and 5.
After adjustment for age, stage, and other factors, the RR for the
middle tertile of the most abundant pesticide, p,p-DDE, was
2.5 (95% CI, 1.0–6.4; Table 4). The RR for the middle tertile
of hexachlorobenzene was 3.0 (95% CI, 1.1–8.4). An increased
risk was not found for the upper tertile of total pesticide
concentrations. Trend tests for all pesticide measurements were
not significant. Among PCB congeners, an increased risk was
found for the upper tertile of BZ 118 relative to the lowest
tertile (RR, 2.9; 95% CI, 1.0–8.5; Table 5). The risk for the
upper tertile of total PCB levels was 2.9 (95% CI, 1.02–8.2).
Nonsignificant increased risks of 2.0 were observed for the
upper tertile of the PCB congeners BZ 138, BZ 153, BZ 167,
BZ 183, and BZ 187 (Table 5). The trend tests did not reach the
level of statistical significance, although the value for BZ 118
was 0.06.
Table 1 Age, race, tumor characteristics, and prognosis of 224 women





















No recurrence 194 (86.6)
Recurrence 30 (13.4)
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There were no significant differences in individual or total
mean pesticide levels by ER status [geometric mean for total
pesticides: 645.5 ng/g (ER women) versus 560.6 ng/g (ER
women)], by progesterone receptor status, or by adjuvant hor-
monal treatment. Total mean PCB levels also did not vary
significantly by ER status [311.5 ng/g (ER women) versus
272.2 ng/g (ER women)], progesterone receptor status, or
adjuvant hormone therapy. Of the 30 recurrences, only 9
women received tamoxifen or other hormone therapy, and
consequently it was not possible to adequately measure the
independent effects of OCs on recurrence stratified by tamox-
ifen status.
Table 6 shows the risk of recurrence associated with other
potential risk factors. Self-reported home termite treatment,
either professionally or personally, was unrelated to breast
cancer recurrence. There was no difference in risk between
black and white/Asian women. Thirty-three women who were
cigarette smokers at the time of diagnosis had a nonsignificant
increase in risk of recurrence (RR, 2.1; 95% CI, 0.9–5.1). There
was no dose-response effect with number of cigarettes smoked
per day. In the follow-up survey, 10 of the women who smoked
reported quitting after diagnosis, although the date of smoking
cessation was not collected. Among women who continued to
smoke, four reported a lower amount of smoking. The RR for
alcohol consumption (1 drink/day) was 0.2 (95% CI, 0.03–
1.8). Tamoxifen treatment was associated with a reduced risk of
breast cancer recurrence (RR, 0.4; 95% CI, 0.2–0.8).
Discussion
In this study the levels of OCs in breast adipose tissue were not
correlated with stage of breast cancer. The highest concentra-
tion of the most abundant pesticide p,p-DDE, was not a sig-
Table 2 Mean concentrations (mean  SD) of adipose pesticides and PCBa






DDT 20.5  33.7 17.5  22.2
DDE 633.9  643.2 507.7  390.9
DDD 23.3  25.6 19.5  9.9
HCB 20.3  11.3 20.7  9.6
-HCH 45.3  243.1 226.3  20.8
TNC 61.4  43.4 68.9  56.7
OXY 54.9  36.9 62.3  43.2
Total pesticides 859.6  811.3 727.4  488.4
Whites 817.8  733.8 742.4  457.4
Blacks 923.3  589.4 720.7  706.1
Asian 3924.9  2969.2 402.6 (n  1)
PCB congener
74 35.5  27.3 44.3  48.1
99 23.7  18.6 26.0  23.4
118 41.3  38.6 48.5  38.4
138 36.4  29.4 28.9  39.8
146 11.3  11.2 8.2  11.8
153 89.2  69.1 96.3  69.1
156 14.2  12.1 15.1  15.2
167 2.5  2.9 2.7  2.6
170 15.5  9.5 13.5  9.0
172 3.9  11.5 2.9  3.6
178 5.1  3.8 5.3  5.6
180 53.4  42.3 57.4  61.9
183 8.5  16.5 7.9  6.1
187 21.0  15.3 21.9  21.7
Total PCB 361.3  235.9 393.4  279.3
Whites 353.9  232.2 369.7  201.1
Blacks 406.7  256.0 529.7  550.8
Asian 594.7  369.2 280.9 (n  1)
a PCB, polychlorinated biphenyl; OC, organochlorinated compound; DDT, 1,1,1-
trichloro-2,2-bis(4-chlorophenyl)ethane; DDE, 1,1-dichloro-2,2-di(4-chlorophe-
nyl)ethylene; DDD, 1,1-dichloro-2-(ortho-chlorophenyl)-2-(para-chlorophenyl)
ethane; HCB, hexachlorobenzene; -HCH, -hexachlorocyclohexane; TNC,
trans-nonachlor; OXY, oxychlordane.
b Nondetects treated as zero.
Table 3 Spearman correlation between log total pesticide and PCBa











a PCB, polychlorinated biphenyl.
Table 4 RRa of breast cancer recurrence associated with adipose
concentrations of organochlorine pesticidesb
Pesticide log
(ng/g) N (recurrent, not recurrent) RR 95% CI
HCB
Lowest tertile 6, 68 1.0 Ref.
Middle tertile 13, 62 3.0 1.1–8.4
Highest tertile 11, 64 2.3 0.7–7.4
-HCH
Lowest tertile 6, 68 1.0 Ref.
Middle tertile 11, 64 1.7 0.6–5.1
Highest tertile 13, 62 2.7 0.9–8.3
OXC
Lowest tertile 9, 65 1.0 Ref.
Middle tertile 10, 65 1.3 0.5–3.1
Highest tertile 11, 64 1.4 0.5–4.0
TNC
Lowest tertile 8, 66 1.0 Ref.
Middle tertile 13, 62 2.0 0.7–5.3
Highest tertile 9, 66 2.1 0.7–6.8
DDE
Lowest tertile 8, 66 1.0 Ref.
Middle tertile 16, 59 2.3 0.9–5.7
Highest tertile 6, 69 1.1 0.4–3.5
DDT
Lowest tertile 9, 65 1.0 Ref.
Middle tertile 13, 62 1.2 0.5–2.9
Highest tertile 8, 67 1.1 0.4–3.0
DDD
Lowest tertile 5, 69 1.0 Ref.
Middle tertile 15, 60 2.2 0.8–6.1
Highest tertile 10, 65 2.3 0.7–8.0
Total pesticides
Lowest tertile 7, 67 1.0 Ref.
Middle tertile 17, 58 2.5 1.0–6.4
Highest tertile 6, 69 1.3 0.4–4.0
a RR, relative risk; CI, confidence interval; HCB, hexachlorobenzene; -HCH,




b Adjusted for age, body mass index, education, stage of disease, tamoxifen
treatment. Tests for trend were not significant.
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nificant 3–5 year predictor of breast cancer recurrence. Inter-
mediate levels of some pesticides were associated with an
increased risk relative to the lowest levels, but the associations
were clearly not dose dependent. In contrast, the risk of recur-
rence was significantly elevated for the highest total PCB
concentrations and for BZ 118. Increased risks of 2.0 were
also observed for the highest levels of several other PCB
congeners, although a dose-dependent effect was not found.
There were relatively few events in this study, and the
positive findings could have been due to bias. It was noted that
patients with stage 3 or stage 4 disease were significantly more
likely to experience a recurrence, providing some assurance
that the study findings were consistent with well-documented
clinical observations. Some data suggest that chemotherapy
alters serum OC levels (10), but all samples were collected
before chemotherapy treatment. There might have been con-
founding from changes in risk factor profiles after the diagno-
sis. For example, obesity adversely affects breast cancer sur-
vival. In our data, there was a very high correlation between
weight at the time of surgery and at the time of follow-up.
Unmeasured confounders might have affected the risk esti-
mates. However, here too we did not observe substantial dif-
ferences in risk estimates between models with varying num-
bers of independent variables. There are an insufficient number
of studies to determine whether our results are consistent with
the literature. In a Danish cohort of 195 breast cancer patients,
the RR of subsequent mortality was unrelated to both blood
pesticide and PCB concentrations but positively related to diel-
drin levels (6).
Some data show or suggest a carcinogenic effect of spe-
cific PCB congeners. Several PCB congeners are tumor pro-
moters in experimental systems, including BZ 118 and BZ 153,
which enhance foci growth in rat liver (11, 12). Mixtures of
TCDD, BZ 118, BZ 153, and other PCB congeners cause liver
enlargement and increased activity of hepatic CYP1A1/2 and
CYP2B1/2 in rats (13). BZ 153, BZ 180, and BZ 138 were
reported to interfere with sexual hormone-regulated processes
in 17-estradiol induced MCF-7 cells, and this was interpreted
as evidence of endocrine disruptive potential (14). BZ 153 has
been shown to alter the secretion of estradiol, progesterone, and
testosterone in porcine ovarian cells (15) and luteal cells (16).
BZ 153 also exhibited estrogenic properties similar to those of
estradiol with respect to increasing serum thyroxine and reduc-
ing follicle-stimulating hormone isoforms in male rats com-
Table 5 RRa of breast cancer recurrence associated with adipose
concentrations of PCBb
PCB congener N (recurrent, not recurrent) RR 95% CI
BZ 74
Lowest tertile 10, 64 1.0 Ref.
Middle tertile 8, 67 1.3 0.5–3.6
Highest tertile 12, 63 1.7 0.6–4.9
BZ 99
Lowest tertile 9, 65 1.0 Ref.
Middle tertile 11, 64 1.1 0.4–2.7
Highest tertile 10, 65 1.7 0.6–4.4
BZ 118
Lowest tertile 6, 68 1.0 Ref.
Middle tertile 11, 64 2.9 1.0–8.5
Highest tertile 13, 62 4.0 1.32–4.9
BZ 138
Lowest tertile 9, 65 1.0 Ref.
Middle tertile 7, 68 1.1 0.4–3.2
Highest tertile 14, 61 2.3 0.8–6.2
BZ 146
Lowest tertile 11, 63 1.0 Ref.
Middle tertile 9, 66 0.8 0.3–2.1
Highest tertile 10, 65 1.6 0.5–5.5
BZ 153
Lowest tertile 10, 64 1.0 Ref.
Middle tertile 7, 68 0.7 0.2–1.9
Highest tertile 13, 62 2.6 1.0–7.1
BZ 156
Lowest tertile 11, 63 1.0 Ref.
Middle tertile 7, 68 0.7 0.3–1.9
Highest tertile 12, 63 1.7 0.6–4.8
BZ 167
Lowest tertile 8, 67 1.0 Ref.
Middle tertile 9, 65 1.3 0.5–3.7
Highest tertile 13, 62 3.1 1.0–9.3
BZ 170
Lowest tertile 12, 62 1.0 Ref.
Middle tertile 8, 67 0.9 0.4–2.5
Highest tertile 10, 65 1.5 0.6–4.2
BZ 172
Lowest tertile 13, 61 1.0 Ref.
Middle tertile 7, 68 0.8 0.3–2.2
Highest tertile 10, 65 1.1 0.5–2.9
BZ 178
Lowest tertile 12, 62 1.0 Ref.
Middle tertile 10, 65 0.7 0.3–1.8
Highest tertile 8, 67 1.1 0.3–3.3
BZ 180
Lowest tertile 11, 63 1.0 Ref.
Middle tertile 11, 64 1.1 0.4–2.9
Highest tertile 8, 67 1.3 0.4–3.8
BZ 183
Lowest tertile 8, 67 1.0 Ref.
Middle tertile 10, 64 1.8 0.7–5.0
Highest tertile 12, 63 2.4 0.9–6.4
BZ 187
Lowest tertile 10, 64 1.0 Ref.
Middle tertile 11, 64 0.9 0.4–2.4
Highest tertile 9, 66 2.3 0.7–7.1
Total PCB
Lowest tertile 9, 65 1.0 Ref.
Middle tertile 8, 67 0.9 0.3–2.6
Highest tertile 13, 62 2.9 1.02–8.2
a RR, relative risk; PCB, polychlorinated biphenyl; CI, confidence interval; Ref.,
referent.
b Adjusted for age, body mass index, education, stage of disease, adjuvant
tamoxifen therapy. Tests for trend were not significant.
Table 6 RRa of breast cancer recurrence associated with baseline risk factors:
reported home pesticide treatment, smoking, alcohol consumption, and
tamoxifen therapyb
Characteristic No.
exposed RR 95% CI
Reference group 1.0
Professional home termite control 89 0.9 0.4–1.9
Reference group 1.0
Personal home termite control 167 0.9 0.3–2.1
Reference group 1.0
Black race 23 1.4 0.5–3.9
Reference group 1.0
Current cigarette smoker 33 2.1 0.9–5.1
Reference group 1.0
Alcohol (GE 1 drink/day) 22 0.3 0.04–2.3
Reference group 1.0
Tamoxifen treatment 115 0.4 0.2–0.8
a RR, relative risk; CI, confidence interval.
b Adjusted for age and body mass index.
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pared to controls (17). However, BZ 138, BZ 153, and BZ 180
did not form DNA adducts or provide evidence of oxidative
stress-induced damage (18). The authors of the Danish survival
study suggested that some OCs might increase the aggressive-
ness of the tumor or affect the growth of malignant cells that
remain after treatment. Some data indicate that higher levels of
PCBs are associated with estrogen-negative tumors, which have
a faster rate of progression. However, the literature in this area
is ambiguous and based on cancer stage (19), and our data set
was too small to examine the risk separately by receptor status.
Nonestrogenic mechanisms by which PCBs might increase
tumor aggressiveness include the induction of cytochrome
P450 1A1 (CYP1A1) gene. An increased risk for breast cancer
was reported for women with the highest blood levels of PCBs
who also possessed CYP1A1 variants (20, 21).
Our finding that smoking affects recurrence suggests that
smoking cessation might be an important means to reduce
further morbidity from breast cancer. Alcohol consumption was
not a factor as has been reported elsewhere (22), although some
data suggest that recurrence risk increases with weekly or more
frequent consumption (23).
In summary, these results suggest that relatively high
PCBs concentrations were related to increased rate of breast
cancer recurrence, although this contrasts with our previous
data showing no effect of OCs on breast cancer risk in these
women. Like the many case-control studies of organochlorine
exposure and breast cancer risk, more studies are needed to
confirm or refute these results.
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